Scope, design, and reporting of prediction models for antineoplastic drugs‐related adverse drug events: A systematic review of machine learning and traditional modeling

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.